Cholangiocarcinoma — evolving concepts and therapeutic strategies

Cited by (1,001)

Items 801–900 of 1,001

1. The expression of Aquaporin-1 and Aquaporin-3 in extrahepatic cholangiocarcinoma and their clinicopathological significance
   Shu Xu, Shengfu Huang, Daiqiang Li, Qiong Zou, Yuan Yuan, Zhulin Yang · 2021 · The American Journal of the Medical Sciences
2. Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration
   Jinglin Song, Xiaofeng Lei, Heng Lin, Haisu Dai, Xingchao Liu, Yan Jiang, Feng Hu, Yuancheng Li, Haining Fan, Leida Zhang et al. · 2022 · PLoS ONE
3. Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
   Alexander Scheiter, Frederik Hierl, Ingrid Winkel, Felix Keil, Margit Klier-Richter, Cédric Coulouarn, Florian Lüke, Arne Kandulski, Matthias Evert, Wolfgang Dietmaier et al. · 2022 · Journal of Personalized Medicine
4. Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?
   Andrea Laurenzi, Giovanni Brandi, Federica Greco, Enrico Prosperi, Andrea Palloni, Matteo Serenari, Giorgio Frega, Matteo Ravaioli, Alessandro Rizzo, Matteo Cescon · 2023 · Langenbeck s Archives of Surgery
5. Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells
   Christian Mayr, Tobias Kiesslich, Dino Bekric, Marlena Beyreis, Michael Kittl, Celina Ablinger, Elen Neureiter, Martin Pichler, Felix Prinz, Markus Ritter et al. · 2023 · PLoS ONE
6. Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial‐mesenchymal transition and stemness by regulating the miR ‐515‐5p/ AKT2 axis and PI3K / AKT / mTOR signaling pathway
   Xin Gao, Shaobo Yu, Sidi Liu, Siyuan Zhang, Xiangjun Sha, Dongsheng Sun, Xingming Jiang · 2023 · Environmental Toxicology
7. Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement
   Hossein Taghizadeh, Angela M. Djanani, Wolfgang Eisterer, Armin Gerger, Birgit Gruenberger, Thomas Gruenberger, Holger F. Rumpold, Lukas Weiß, Thomas L. Winder, Ewald Wöll et al. · 2023 · Frontiers in Oncology
8. LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway
   Guoqing Zhou, Hongwei He, Xu'an Wang, Qiyun Gu · 2023 · Heliyon
9. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
   Jiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, Weiqing Chen · 2024 · Pharmaceutical Biology
10. Causal roles of gut microbiota in cholangiocarcinoma etiology suggested by genetic study
    Zhitao Chen, Chenchen Ding, Kailei Chen, Yangjun Gu, Chi‐Cheng Lu, Qiyong Li · 2024 · World Journal of Gastrointestinal Oncology
11. Huaier inhibits cholangiocarcinoma cells through the twist1/FBP1/Wnt/β-catenin axis
    Liyuan Cong, Jian Shi, Jing Zhao, Kun Li, Dongdong Dai, Bingyuan Zhang, Wei Zhao · 2024 · Molecular Biology Reports
12. Identification of autoantibodies as potential non-invasive biomarkers for intrahepatic cholangiocarcinoma
    Wachira Kajornsrichon, Jittiporn Chaisaingmongkol, Yotsawat Pomyen, Phanthakarn Tit-oon, Xin Wei Wang, Mathuros Ruchirawat, Mayuree Fuangthong · 2024 · Scientific Reports
13. Associations between metabolic syndrome and cholangiocarcinoma risk: A large-scale population-based cohort study
    Tzu-I Chen, Minghuang Chen, Szu‐Ching Yin, Chih-Jo Lin, Tram Kim Lam, Chia-Wei Huang, Yi‐Ting Chen, Xia-Rong Liu, Yun-Zheng Gao, Wan‐Lun Hsu et al. · 2025 · Hepatology
14. Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma
    Sirinya Sitthirak, Sittiruk Roytrakul, Arporn Wangwiwatsin, Nisana Namwat, Poramate Klanrit, Hasaya Dokduang, Prakasit Sa-Ngiamwibool, Attapol Titapan, Apiwat Jareanrat, Vasin Thanasukarn et al. · 2025 · Scientific Reports
15. Evaluation of Primary Liver Cancers Using Hepatocyte‐Specific Contrast‐Enhanced MRI : Pitfalls and Potential Tips
    Jae Hyun Kim, Jeong Hee Yoon, Ijin Joo, Jeong Min Lee · 2020 · Journal of Magnetic Resonance Imaging
16. Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature
    Zhenjiang Ma, Heping Li, Liangshuai Liu · 2021 · Recent Patents on Anti-Cancer Drug Discovery
17. A redox probe screens MTHFD1 as a determinant of gemcitabine chemoresistance in cholangiocarcinoma
    Ruogu Pan, Zhiqing Yuan, Yingbin Liu, Xuxu Sun, Guiyang Wang, Xiaopen Wang, Junwen Qu, Jian Wang, Jie Yang, Yuzheng Zhao et al. · 2021 · Cell Death Discovery
18. Minimally Invasive Surgery for Intrahepatic Cholangiocarcinoma: Patient Selection and Special Considerations
    Mackenzie Owen, Eliza Wright Beal · 2021 · Hepatic Medicine Evidence and Research
19. CEACAM6 promotes cholangiocarcinoma migration and invasion by inducing epithelial‑mesenchymal transition through inhibition of the SRC/PI3K/AKT signaling pathway
    Chen Liu, Min Wang, Haitao Lv, Bing Liu, Xueqiang Ya, Weihong Zhao, Wenbin Wang · 2021 · Oncology Letters
20. Crowberry inhibits cell proliferation and migration through a molecular mechanism that includes inhibition of DEK and Akt signaling in cholangiocarcinoma
    Xue Wang, Xuebing Zhou, Ludan Zhang, Xin Zhang, Chunyu Yang, Yingshi Piao, Jinhua Zhao, Lili Jin, Guihua Jin, Ren‐Bo An et al. · 2022 · Chinese Medicine
21. Effects of 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione on autophagy and the PI3K/AKT/mTOR signaling pathway in human cholangiocarcinoma QBC939 cells
    Yongfei He, Yanghong Li, Tianyi Liang, Shutian Mo, Yuan Liao, Zijun Chen, Shuqi Zhao, Qingfu Ran, Chuangye Han, Pham Thi Thai Hoa · 2022 · Journal of Gastrointestinal Oncology
22. Potential of Alpha-Mangostin-Loaded PLGA Nanoparticles for Cholangiocarcinoma Treatment
    Asma Tahir, Tullayakorn Plengsuriyakarn, Chuda Chittasupho, Kesara Na‐Bangchang · 2022 · Polymers
23. Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Alessandro Rizzo, Massimiliano Salati, Giorgio Frega, Valeria Merz, Francesco Caputo, Alessandro Di Federico, Andrea Palloni, Riccardo Carloni, Angela Dalia Ricci, Gennaro Gadaleta‐Caldarola et al. · 2022 · Medicina
24. A meta-analysis of based radiomics for predicting lymph node metastasis in patients with biliary tract cancers
    Yuhu Ma, Yanyan Lin, Jiyuan Lu, Yulong He, Qianling Shi, Haoran Liu, Jianlong Li, Baoping Zhang, Jinduo Zhang, Yong Zhang et al. · 2023 · Frontiers in Surgery
25. SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis
    Fanghua Chen, Ling Aye, Lei Yu, Longzi Liu, Yuming Liu, Youpei Lin, Dongmei Gao, Qiang Gao, Shu Zhang · 2023 · Carcinogenesis
26. Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas
    Xiaohong Pu, Liang Qi, Jia Wu Yan, Zihe Ai, Ping Wu, Fei Yang, Yao Shi Fu, Xing Li, Min Zhang, Beicheng Sun et al. · 2023 · Cell & Bioscience
27. Long‐term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma
    Clémentine Alitti, Agnès Rode, Hervé Trillaud, Philippe Merle, Jean‐Frédéric Blanc, Lorraine Blaise, Alix Demory, G. Nkontchou, Véronique Grando, Marianne Ziol et al. · 2024 · Liver International
28. Intrahepatic cholangiocarcinoma as a rare secondary malignancy after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia: A case report
    Meghan L. Good, Parisa Malekzadeh, Isaac R. Kriley, Nirali N. Shah, David Erwin Kleiner, Katherine R. Calvo, Jonathan Matthew Hernandez, Jeremy L. Davis · 2020 · Pediatric Transplantation
29. Analysis of Patients With Incidental Perihilar Cholangiocarcinoma: An Old and a Persistent Burden for Liver Transplantation
    Maciej Krasnodębski, Michał Grąt, Michał Wierzchowski, Michalina Szczęśniak, Marcin Morawski, Krzysztof Zając, Waldemar Patkowski, Krzysztof Zieniewicz · 2020 · Transplantation Proceedings
30. Pathological aspects of mucinous cholangiocarcinoma: A single‐center experience and systematic review
    Thiyaphat Laohawetwanit, Naruemon Klaikaew · 2020 · Pathology International
31. SOX2 knockdown slows cholangiocarcinoma progression through inhibition of transcriptional activation of lncRNA PVT1
    A.M.Y. Yu, Luwen Zhao, Qingmin Kang, Jian Li, Kai Chen, Hua Fu · 2020 · Biochemical Journal
32. Mesencephalic Astrocyte-Derived Neurotrophic Factor, a Prognostic Factor of Cholangiocarcinoma, Affects Sorafenib Sensitivity of Cholangiocarcinoma Cells by Deteriorating ER Stress
    Jingyi He, Guangbing Li, Xihan Liu, Liye Ma, Jiayao Zhang, Shunzhen Zheng, Jianping Wang, Jun Liu · 2020 · OncoTargets and Therapy
33. Cholangiocarcinoma Therapeutics: An Update
    Mai Ly Thi Nguyen, Nguyễn Lĩnh Toàn, Maria Bożko, Khắc Cường Bùi, Przemyslaw M. Bozko · 2021 · Current Cancer Drug Targets
34. Current challenges to underpinning the genetic basis for cholangiocarcinoma
    Antonio Cigliano, Xin Chen, Diego Francesco Calvisi · 2021 · Expert Review of Gastroenterology & Hepatology
35. The role of bile acid subtypes in the diagnosis of cholangiocarcinoma
    Wei Wang, Shi‐Lin Tian, Die Jin, Bin Liu, Wujie Wang, Haiyang Chang, Chao Chen, Zhe Yu, Yong‐Zheng Wang, Yuliang Li · 2021 · Asia-Pacific Journal of Clinical Oncology
36. The association of carbohydrate antigen 19‐9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort study
    Quan‐Yu Cai, Ping Yang, Xiao‐Liang Yang, Xiang‐Hua Zhang, Lie‐Ping Guo, Xinyuan Lu, Lei Huo, Hongbin Ma, Xiangdong Wang, Huabang Zhou et al. · 2023 · Cancer
37. Beyond the Bile: Exploring the Microbiome and Metabolites in Cholangiocarcinoma
    Jungnam Lee, Hanul Kim, Jin‐Seok Park · 2024 · Life
38. Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma
    Rabea Margies, Lisa-Katharina Gröger, Beate Katharina Straub, F. Bartsch, Hauke Lang · 2024 · Cancers
39. Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma
    Yu‐Hsuan Kuo, Khaa Hoo Ong, Ding‐Ping Sun, Yufeng Tian, Chia‐Ling Chou, Ti‐Chun Chan, Chung‐Hsi Hsing, Wan‐Shan Li, Chien‐Feng Li, Yow‐Ling Shiue · 2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
40. Circ_0084927 promotes progression of intrahepatic cholangiocarcinoma by sponging miR-4725-5p to activate the PDPK1/AKT/mTOR signaling pathway
    Chenxi Xie, Gengping Zhou, Taiyang Chen, Qingshan Li, Hao Yuan, Yang Xu, Kai Zhang, Chunmei Wang, Xiaopei Hao, Haibo Yu · 2025 · Cellular Signalling
41. IFN-γ enhances Poly(I:C)-induced necroptosis and immunogenic cell death via TLR3 upregulation in cholangiocarcinoma cells
    Apiwit Sae-Fung, Thanpisit Lomphithak, Nattaya Duangthim, Siriporn Jitkaew · 2025 · European Journal of Pharmaceutical Sciences
42. Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
    Dong‐Gi Mun, Erik Jessen, Jennifer L. Tomlinson, Danielle Marie Carlson, Rohit Budhraja, Roberto Alva‐Ruiz, Amro M. Abdelrahman, Ryan D. Watkins, Lindsey A. Gregory, Chantal E. McCabe et al. · 2025 · Hepatology
43. Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumors
    Mohamed E. Abdelsalam, Kamran Ahrar, Rahul A. Sheth, Ketan Y. Shah, Steven M. Yevich, Varshana Gurusamy, Bruno Calazans Odisio, Alda Lui Tam, Armeen Mahvash, Peiman Habibollahi · 2025 · CA A Cancer Journal for Clinicians
44. Liquid biopsy in biliary tract cancers: early diagnosis, precision therapy, and prognostic evaluation
    Guanhua Wu, Xinjian Xu, Honghua Zhang, Peng Li, Chao Liu · 2025 · Frontiers in Oncology
45. L-lactate-driven PSMD14 lactylation and stabilization promote lactate production and ferroptosis resistance via ENO1 in intrahepatic cholangiocarcinoma
    Dong Cai, Guo‐Chao Zhong, Zhibo Zhao, Menglin Chen, Qing Tao, Xin Dai, Degong Jia, LVE CHENG, Zhenru Wu, Shengwei Li et al. · 2026 · Cancer Letters
46. Spatiotemporal regulation of cholangiocarcinoma growth and dissemination by peritumoral myofibroblasts in a Vcam1-dependent manner
    Cheng Lin Tian, Liyuan Li, Qingfei Pan, Beisi Xu, Yizhen Li, Fan Li, Anthony Ray Brown, Michelle Morrison, Kaushik Dey, Jun J.J. Yang et al. · 2023 · Oncogene
47. Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy
    Andrea Casadei Gardini, Francesco Leone, Giovanni Brandi, Mario Scartozzi, Nicola Silvestris, Daniele Santini, Luca Faloppi, Massimo Aglietta, Maria Antonietta Satolli, Alessandro Rizzo et al. · 2023 · Frontiers in Oncology
48. Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion
    Valeria Lucarini, Daniela Nardozi, Valentina Angiolini, Monica Benvenuto, Chiara Focaccetti, Raffaele Carrano, Zein Mersini Besharat, Roberto Bei, Laura Masuelli · 2023 · Biomedicines
49. Safety and efficacy of biliary stenting combined with iodine-125 seed strand followed by hepatic artery infusion chemotherapy plus lenvatinib with PD-1 inhibitor for the treatment of extrahepatic cholangiocarcinoma with malignant obstructive jaundice
    Long-Wang Lin, Kun Ke, Rong Chen, Wei-Zhu Yang, Ning Huang, Zhengzhong Wu · 2024 · Frontiers in Immunology
50. Regulation of lipid metabolism by APOE4 in intrahepatic cholangiocarcinoma via the enhancement of ABCA1 membrane expression
    Liqiang Qian, Gang Wang, Bin Li, Haoyuan Su, Lei Qin · 2024 · PeerJ
51. Updates in Diagnosis and Endoscopic Management of Cholangiocarcinoma
    Roxana-Luiza Caragut, Mădălina Ilie, Teodor Cabel, Deniz Günșahin, Afrodita Panaitescu, Christopher Jesse Vlad Pavel, Oana‐Mihaela Plotogea, Ecaterina Mihaela Rinja, Gabriel Constantinescu, Vasile Şandru · 2024 · Diagnostics
52. Transcription factor EHF drives cholangiocarcinoma development through transcriptional activation of glioma‐associated oncogene homolog 1 and chemokine CCL2
    Yiming Luo, Zhi Li, He Zhu, Junli Lu, Zhen Lei, Su Chen, Furong Liu, Hongwei Zhang, Qibo Huang, Shenqi Han et al. · 2024 · MedComm
53. Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study
    Bo Chen, Mengmeng Lü, Qi‐Wen Chen, Enguang Zou, Zhiyuan Bo, Jiacheng Li, Rui Zhao, Jungang Zhao, Zhengping Yu, Gang Chen et al. · 2024 · Frontiers in Genetics
54. Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies
    Yidan Lou, Yijing Chen, Kaibo Guo, Binbin Li, Song Zheng · 2024 · Biomarkers in Medicine
55. Survival analysis and prognostic nomogram for patients with cholangiocarcinoma after radical resection in Asia
    Yongchang Tang, Lei Xu, Gening Zhang, Kangshuai Li, Anda Shi, Lizhuang Shu, Liming Zhao, Enshan Li, Kejian Sun, Guozheng Pan et al. · 2024 · European Journal of Surgical Oncology
56. Tumor budding in pre-neoadjuvant biopsy and post-neoadjuvant resection specimens is associated with poor prognosis in intrahepatic cholangiocarcinoma—a cohort study of 147 cases by modified ITBCC criteria
    Gaohua Wu, Rongkui Luo, Qianhui Xu, Liu‐Xiao Yang, Hongping Xia, Valerie Chew, Ye Xin Koh, Kenneth Tou En Chang, Jian Zhou, Jia Fan et al. · 2024 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
57. Umbrella review of adjuvant photodynamic therapy for cholangiocarcinoma palliative treatment
    Hanhan Chen, Honglin Li, Huijie Li, Zhen Zhang · 2025 · Photodiagnosis and Photodynamic Therapy
58. Bile-Derived cfDNA of Syncytin-1 and SLC7A11 as a Potential Molecular Marker for Early Diagnosis of Cholangiocarcinoma
    Jing He, Jingrong Qian, Xin Li, Xiaoyue Zhao, Weiwei Meng, Xuewei Zhuang · 2025 · Journal of Gastrointestinal Cancer
59. Multiple-omics analysis reveals a dedifferentiation-immune loop in intrahepatic cholangiocarcinoma
    Jian Ruan, Qiong Li, Yuzhi Jin, Jie Yin, Chanqi Ye, Fei Cheng, Shuaishuai Xu, Ruyin Chen, Chuan Liu, Xiaoxiang Rong et al. · 2025 · Molecular Therapy
60. Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma
    Aimen O. Amer, Colin Hugh Wilson, Derek Manas · 2019 · European Journal of Surgical Oncology
61. Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma
    Yunxia Liu, Xia Liu, Yanhua Zhou, Tingting Liu, Jie Li · 2020 · Clinical and Experimental Medicine
62. Anti-tumor activity of rice bran hydrolysates on migration, invasion and angiogenesis
    Suphanthip Phusrisom, Laddawan Senggunprai, Auemduan Prawan, Sarinya Kongpetch, Upa Kukongviriyapan, Supawan Thawornchinsombut, Sirithon Siriamornpun, Theeraphan Chumroenphat, Ronnachai Changsri, Veerapol Kukongviriyapan · 2021 · Asian Pacific Journal of Tropical Biomedicine
63. Is surgery justified for elderly patients with extrahepatic cholangiocarcinoma? Reappraisal from a viewpoint of comorbidity and organ function
    Tatsuaki Sumiyoshi, Kenichiro Uemura, Naru Kondo, Kenjiro Okada, Shingo Seo, Hiroyuki Otsuka, Masahiro Serikawa, Yasutaka Ishii, Tomofumi Tsuboi, Yoshiaki Murakami et al. · 2021 · Surgery Today
64. Addition of thermal ablation to systemic chemotherapy for the treatment of unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis
    Yan Xia, Liping Zhuang, Zhouyu Ning, Peng Wang, Zhiqiang Meng · 2021 · Expert Review of Gastroenterology & Hepatology
65. The reality of cholangiocarcinoma in India– real world data from a tertiary referral centre
    Shraddha Patkar, Vikas Gupta, Krunal Khobragade, Mahesh Goel · 2022 · HPB
66. Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma
    Raksawan Deenonpoe, Prakasit Sa-Ngiamwibool, Sasithorn Watcharadetwittaya, Malinee Thanee, Kitti Intuyod, Thachanan Kongpan, Sureerat Padthaisong, Rungtiwa Nutalai, Yaovalux Chamgramol, Chawalit Pairojkul · 2022 · Scientific Reports
67. Liver kinase B1 in exosomes inhibits immune checkpoint programmed death ligand 1 and metastatic progression of intrahepatic cholangiocarcinoma
    Zhuo Liu, Kunyan Zhou, Jian Zeng, Xin Zhou, Huanyu Li, Ke Peng, Xiang Liu, Feng Feng, Bin Jiang, Ming Zhao et al. · 2022 · Oncology Reports
68. Validated UPLC-MS/MS Method for Determination of Futibatinib and Its Pharmacokinetics in Beagle Dogs
    Heng Li, Hao‐zhe Ding, Yi-Lin Wang, Feng Zhang, Ya-Hao Song, Xiangjun Qiu · 2022 · Journal of Chemistry
69. Low Complement Factor H-Related 3 (CFHR3) Expression Indicates Poor Prognosis and Immune Regulation in Cholangiocarcinoma
    Haoran Wang, Meng He, Zheng Zhang, Wenze Yin, Bixuan Ren, Yujia Lin · 2022 · Journal of Oncology
70. Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress
    Gennaro Gadaleta‐Caldarola, Alessandro Rizzo, Vincenzo Dadduzio, Lucia Lombardi, Arianna Gadaleta-Caldarola, Stefania Infusino, Antonio Cusmai, Claudia Citrigno, Gennaro Palmiotti · 2022 · Current Oncology
71. MLN2238 exerts its anti-tumor effects via regulating ROS/JNK/mitochondrial signaling pathways in intrahepatic cholangiocarcinoma
    Hao Xu, Guangyu Xu, Qianhui Xu, Chang Xu, Xiaohu Zhou, Yang Bai, Lu Yin, Yuan Ding, Weilin Wang · 2022 · Frontiers in Pharmacology
72. Aquaporin 1 is a prognostic marker and inhibits tumour progression through downregulation of Snail expression in intrahepatic cholangiocarcinoma
    Meng-Qi Zhuang, Xiao-Lan Jiang, Wen-Di Liu, Qiao-Hua Xie, Peng Wang, Liwei Dong, He-Ping Hu, Huabang Zhou, Yu-Bao Zhou · 2023 · Digestive and Liver Disease
73. Microsomal Prostaglandin E Synthase-1 and -2: Emerging Targets in Non-Alcoholic Fatty Liver Disease
    Dimitrios Kotsos, Κωνσταντίνος Τζιόμαλος · 2023 · International Journal of Molecular Sciences
74. How Can Machine Perfusion Change the Paradigm of Liver Transplantation for Patients with Perihilar Cholangiocarcinoma?
    Damiano Patrono, Fabio Colli, Matteo Colangelo, Nicola De Stefano, Ana Lavinia Apostu, Elena Mazza, Silvia Catalano, Giorgia Rizza, Stefano Mirabella, Renato Romagnoli · 2023 · Journal of Clinical Medicine
75. Development and validation of machine learning models for predicting prognosis and guiding individualized postoperative chemotherapy: A real-world study of distal cholangiocarcinoma
    Di Wang, Bing Pan, Jincan Huang, Qing Chen, Songping Cui, Ren Lang, Shaocheng Lyu · 2023 · Frontiers in Oncology
76. Durvalumab in Advanced Cholangiocarcinoma: Is Someone Knocking Down the Door?
    Angela Dalia Ricci, Rosalba D’Alessandro, Alessandro Rizzo, Annalisa Schirizzi, Simona Vallarelli, Carmela Ostuni, Laura Troiani, Ivan Roberto Lolli, Claudio Lotesoriere, Gianluigi Giannelli · 2023 · Immunotherapy
77. The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma
    Jianping Wang, Man Shu, Hong Peng, Shaoqiang Li, Dongming Li, Jingxian Shen, Ming Kuang, Ying Zhang, Zebin Chen · 2023 · Annals of Surgical Treatment and Research
78. Glucose metabolic upregulation via phosphorylation of S6 ribosomal protein affects tumor progression in distal cholangiocarcinoma
    Atsuro Fujinaga, Teijiro Hirashita, Yuka Hirashita, Kumiko Sakai, Masahiro Kawamura, Takashi Masuda, Yuichi Endo, Masayuki Ohta, Kazunari Murakami, Masafumi Inomata · 2023 · BMC Gastroenterology
79. A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence
    James Moroney, Juan Pablo Trivella, Ben George, Sarah Beth White · 2023 · Cancers
80. Liver Transplantation for Colorectal Liver Metastases
    Emily J. Schepers, Stephen J. Hartman, Jenna N. Whitrock, Ralph C. Quillin · 2023 · Surgical Clinics of North America
81. Downregulation of JAM3 occurs in cholangiocarcinoma by hypermethylation: A potential molecular marker for diagnosis and prognosis
    Yi Ping Shi, Xiao Shan Feng, Ying Zhang, Ji Gao, Wei Bao, Jiandong Wang, Jian‐feng Bai · 2023 · Journal of Cellular and Molecular Medicine
82. Development and validation of a clinical prediction model for the risk of distal metastasis in intrahepatic cholangiocarcinoma: a real-world study
    Caixia Fang, Chan Xu, Xiaodong Jia, Xiaoping Li, Chengliang Yin, Xiaojuan Xing, Wenle Li, Zhenyun Wang · 2024 · BMC Gastroenterology
83. Molecular Biomarkers in Cholangiocarcinoma: Focus on Bile
    Andrey D. Dolbnya, Igor A. Popov, Пеков Станислав Игоревич · 2024 · Current Topics in Medicinal Chemistry
84. The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis
    G. Huang, Pu Xi, Zehui Yao, Chongyu Zhao, Xiaohui Li, Zexian Chen, Xiaojun Lin · 2024 · Journal of Inflammation Research
85. Management of Combined Hepatocellular Carcinoma-Cholangiocarcinoma
    Ju Dong Yang, Lewis Rowland Roberts · 2018 · Current Hepatology Reports
86. Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review
    Beslan Nuralievich Gurmikov, Yu. A. Kovalenko, Vladimir Aleksandrovich Vishnevsky, Alexey V. Chzhao · 2019 · Advances in molecular oncology
87. Cholangiocarcinoma Following Bariatric Surgery: a Prospective Follow-Up Single-Center Audit
    Nassiba Beghdadi, Chétana Lim, Judith Aron‐Wisnewsky, Adriana Torcivia, Claire Goumard, Célia Turco, Jean‐Christophe Vaillant, Jean‐Michel Siksik, Jean‐Michel Oppert, Olivier Scatton et al. · 2020 · Obesity Surgery
88. Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma
    Yong Wang, Zhongran Man, Xiaosi Hu, Lei Zhou, Hao Jin, Huichun Liu, Qing Pang · 2021 · International Journal of Clinical Oncology
89. Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
    Annamaria Massa, Caterina Peraldo Neia, Francesca Vita, Chiara Varamo, Marco Basiricò, Chiara Raggi, Paola Bernabei, Jessica Erriquez, Ivana Sarotto, Francesco Leone et al. · 2022 · Frontiers in Oncology
90. N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas
    Tiemo Sven Gerber, Benjamin Frank Goeppert, Anne Hausen, Hagen Roland Witzel, F. Bartsch, Mario Schindeldecker, Lisa-Katharina Gröger, Dirk Andreas Ridder, Oscar Cahyadi, Iréne Esposito et al. · 2022 · Cancers
91. Exhaled volatile organic compounds for cholangiocarcinoma diagnosis
    Nanicha Siriwong, Thanikan Sukaram, Rossarin Tansawat, Terapap Apiparakoon, Thodsawit Tiyarattanachai, Sanparith Marukatat, Rungsun Rerknimitr, Roongruedee Chaiteerakij · 2022 · Liver Research
92. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation
    Jiena Wang, Weiwei Zhu, Junxue Tu, Yihui Zheng · 2022 · Journal of Microbiology and Biotechnology
93. The future of fibroblast growth factor receptor inhibitors and mechanisms of resistance for cholangiocarcinoma
    Samantha M. Ruff, Sameek Roychowdhury, Timothy Michael Pawlik · 2023 · Expert Opinion on Pharmacotherapy
94. Gemcitabine, Cisplatin, and nab-Paclitaxel for Patients With Advanced Biliary Tract Cancer
    Marc Roth, Laura Williams Goff · 2019 · JAMA Oncology
95. Perihilar Cholangiocarcinoma
    Meryl C. Nath, Michael S Torbenson, Lori A. Erickson · 2018 · Mayo Clinic Proceedings
96. Combination systemic therapies with immune checkpoint inhibitors in biliary tract cancer: effective but not enough?
    Alessandro Rizzo, Antonio Cusmai, Angela Dalia Ricci, Giovanni Brandi, Gennaro Palmiotti · 2022 · Expert Review of Gastroenterology & Hepatology
97. Advancing Cholangiocarcinoma Diagnosis: The Role of Liquid Biopsy and CRISPR/Cas Systems in Biomarker Detection
    Agne Sidabraite, Paula Lucia Mosert, Uzair Ahmed, Stephen K. Jones, Aistė Gulla · 2025 · Cancers
98. Targeting xanthine oxidoreductase reverses resistance to EGFR tyrosine kinase inhibitors in intrahepatic cholangiocarcinoma
    Jianbo He, Minglu Zhang, Yuze Shi, Zetao Ji, Yijun Lu, Weiwei Yu, Fei Wang, Qifei Guan, Hongyao Yan, Guanghou Chen et al. · 2025 · Journal of Hepatology
99. Clinical association between inflammatory bowel disease and primary sclerosing cholangitis: what changes after colectomy and liver transplantation?
    Shanshan Wang, Alisa Farokhian, Bo Shen · 2025 · eGastroenterology
100. Advances in Endoscopic Diagnosis and Management of Cholangiocarcinoma
     Usamah N. Chaudhary, Shawn L. Shah · 2025 · Journal of Clinical Medicine